Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
It is administered as part of a structured treatment plan by qualified professionals
View Article Thomas JG, et al
Rather than leaning on one mechanism, it's built to support the whole recovery process at once
23 If your website uses the word generic, you have already lost
1-sided p-value evaluated at 2.5% level for superiority 14.4 Safety Outcomes Trial DEVOTE (NCT01959529) Cardiovascular Outcomes Trial of TRESIBA Administered Once-Daily Between Dinner and Bedtime in Combination with Standard of Care in Subjects with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease DEVOTE was a multi-center, multi-national, randomized, double-blinded, active-controlled, treat-to-target, event-driven trial
W.FrankeA
US$ 22.36
US$ 28.17
US$ 28.47
